
Conference Coverage
about 1 month ago
Objective Testing for ADHD: Latest Tests and Benefitsabout 1 month ago
Conversations in ADHD: Highlights From APSARD 2026Latest Content

What Is the Relationship Between Food and Mood?

Phase 3 Brilliance Studies Initiated on Alixorexton for the Treatment of Narcolepsy Type 1 and Type 2

Presenting Our April 2026 Theme: Schizophrenia

The Psychiatric Pipeline in Review: Quarter 1, 2026

Adapting Psychiatric Training to the Chatbot Revolution

Shorts










Digital Edition
Podcasts
Continuing Medical Education
All News

Being a fool can run from being thought to be inappropriately silly to Shakespeare’s fools of creative wisdom. Where does psychiatry come in?

Elite coaches often run on severe sleep loss, risking impaired decisions, emotion control, and leadership.

Continuity vs discontinuity, tradition vs change in the “psy disciplines.”

Check out the pipeline updates from March!

Further data shared on LB-102 for schizophrenia.

A panel of experts presented new consensus recommendations focused on the screening, diagnosis, and treatment of tardive dyskinesia among older adults in long-term care settings.

Tazbentetol interim results show improvement in schizophrenia symptoms.

ASAM announces new youth substance use disorder criteria, promoting early intervention, family-focused care, integrated mental health, and updated levels of treatment.

Why men struggle in silence: suicide risks, hidden depression signs, and practical ways therapy and connection help.

How medical conferences cut carbon footprint: greener travel, water stations, compostables, recycled badges, and offsets—AAP’s 2025 model.

LB Pharmaceuticals has initiated the pivotal phase 3 NOVA-2 trial evaluating the efficacy and safety of LB-102 as a treatment for schizophrenia.

Learn more about why shared decision-making fails across cultures—and how a quick wind-check helps clinicians adapt recovery care without losing trust.

Resort thrillers glamorize hotel killings, but data reveals a quieter risk: planned suicides by local guests—and warning signs clinicians can spot.

New lawsuits target social media and chatbots that could reshape AI regulation and protect youth mental health.

Near 80, a psychiatrist rediscovers joy in family, music, and purpose—while facing mortality and the bittersweet truths of aging.









































